Remove International Remove Protein Production Remove Therapies
article thumbnail

Sino Biological: new US centre for bioprocessing

Drug Target Review

About Sino Biological Sino Biological is an international reagent supplier and contract research service provider. The company specialises in recombinant protein production and antibody development. We are pleased to welcome them to Houston.”

article thumbnail

Series A Financing of 570 Million Yen Procured by Epsilon Molecular Engineering: A Next-Generation Medium Sized Molecular Biotechnology-Based Drug Discovery Firm

The Pharma Data

We will leverage this financing to accelerate collaborative research with pharmaceutical manufacturers and internal research using its own pipeline. Using the obtained sequencing data, Kao Corporation was able to produce an antibody sample in one week using protein production technology such as enzymes cultivated by our technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Beyond Steel Tanks

Codon

million liters in 2021, according to an analysis by BioProcess International. market with Wegovy will, by 2030, require about one million liters of production capacity. In 2012, an Israeli company called Protalix gained approval for their plant-based enzyme product for Gaucher’s disease.

article thumbnail

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

Draft guidance on potency assays for CGT products garners extensive stakeholder input Late last year, the FDA published a draft update to its 2011 guidance on potency assays for cell and gene therapy products, unveiling a major shift in approach to the issue. How does “potency” apply to cell and gene therapy (CGT) products?

article thumbnail

Codon Digest: Discovering Antibiotics with Deep Learning

Codon

This means that IscB base editors might be easier to package inside of AAVs, which can only store 4,700 bases of DNA for gene therapies. 3/ Cell Membrane Editor A cell is a lipid shell with lots of DNA, proteins, and RNA molecules inside. Molecular Therapy. Read Novartis bought a blood stem cell gene therapy program for $87.5

DNA 52
article thumbnail

Codon Digest: Discovering Antibiotics with Deep Learning

Codon

This means that IscB base editors might be easier to package inside of AAVs, which can only store 4,700 bases of DNA for gene therapies. 3/ Cell Membrane Editor A cell is a lipid shell with lots of DNA, proteins, and RNA molecules inside. Molecular Therapy. Read Novartis bought a blood stem cell gene therapy program for $87.5

DNA 52